Kurzfassung

Phase III Randomized, Multi Center Study of Sunitinib Malate (SU 011248) or
Capecitabine in Subjects with Advanced Breast Cancer who failed both a taxane and an anthracycline chemotherapy regimen or failed with a taxane and for whom further anthracycline therapy is not indicated.